1 year return (CAGR)
-14.90%
Audax Renovables S.A. Exchange (MC, EUR)
ADX.MC
1.11
+0.03 (+3.07%)
UtilitiesUtilities - Renewable
Loading...
3 year return (CAGR)
-3.83%
5 year return (CAGR)
-1.38%
10 year return (CAGR)
8.61%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
507.97M
Price/Sales
0.27
Ent value
1.39B
Price/Book
2.15
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-1.24%
Trailing P/E
42.52
PEG
-
Forward P/E
10.38
EPS growth
-6.20%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.12 |
| Daily high | 1.17 |
| Daily low | 1.11 |
| Daily Volume | 739K |
| All-time high | 9.72 |
| 1y analyst estimate | 2.35 |
| Beta | 1.11 |
| EPS (TTM) | 0.03 |
| Dividend per share | 0.00 |
| Ex-div date | 1 Jul 2026 |
| Next earnings date | 28 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ADX.MC | S&P500 | |
| Current price drop from All-time high | -88.54% | -2.82% |
| Highest price drop | -97.22% | -56.47% |
| Date of highest drop | 25 Apr 2013 | 9 Mar 2009 |
| Avg drop from high | -80.37% | -10.64% |
| Avg time to new high | 71 days | 12 days |
| Max time to new high | 4934 days | 1805 days |
News
Novartis will now approach regulators in a bid to expand Rhapsido’s label as analysts foresee a blockbuster future for the drug.
November 13, 2026
OHB (ETR:OHB) confirmed its 2026 guidance after reporting higher operating performance and profitability for the first nine months of the year, as major satellite contracts expanded its order book and...
November 12, 2026
RemIND data show clinically meaningful responses through Week 52 across three most prevalent CIndU subtypes, including after switching from placebo at Week 241Twice as many Rhapsido-treated patients a...
November 12, 2026
Does Novartis (NVS) have what it takes to be a top stock pick for momentum investors? Let's find out.
November 12, 2026
Dublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "Thin Film Drug Manufacturing - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global thin film drug manufact...
November 12, 2026
De'Longhi shares have had a strong few years, which naturally raises the question of whether the current price properly lines up with the cash the business is expected to generate. With the stock rece...
November 12, 2026
GREENWICH, Conn., November 12, 2026--QXO, Inc. (NYSE: QXO) today announced the appointment of Dev Ahuja as the company’s Chief Financial Officer. He will succeed Ihsan Essaid, who has been promoted to...
November 12, 2026
REGULATORY INFORMATION Paris, November 12, 2026 Ramsay Santé obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia Ramsay Santé today announces that the ...
November 12, 2026
As part of the ongoing execution of the German power cables project SuedLink, NKT has reached a milestone for the crossing of the River Elbe, one of Germany's largest rivers. The company has successfu...
November 12, 2026
OTP Bank PLC (OTPBF) delivered 12% organic loan growth, a 4.6% net interest margin, and a 17.8% CET1 ratio, but one-off provisions, rising costs, and special taxes weighed on profit growth.
November 12, 2026